Heart-felt Achievement - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Heart-felt Achievement
10 Oct 2019

Gleneagles Hospital Hong Kong marked another milestone on 11 October 2019 by being the first private hospital in Asia to perform a left atrial appendage closure surgery using a newly modified device that reduces the risk of stroke in patients. This coincided with the hospital’s expansion of its Cardiology Clinic in October 2019, showcasing its aspirations to be a leading specialist in this field.

Dr Tse Tak Sun, Director, Cardiac Catheterization Laboratory at Gleneagles Hong Kong, explained that left atrial appendage occlusion (LAAO) is a treatment strategy to reduce the risk of left atrial appendage blood clots formation causing a stroke in patients with non-valvular atrial fibrillation. In patients with high risk of stroke, the standard treatment is blood thinning medications, however, some patients may not be able to tolerate this type of medication treatment. In that circumstance, the LAAO is an implant-based alternative to blood thinners.

Dr Tse added that the new generation WATCHMAN LAAC device has better control for intuitive, safe and precise positioning. The device is also easier to deploy which may potentially improve procedural success rate, minimise metal exposure and enhance conformability, which can lead to better seal and lower complication rate.

Having performed more than 650 cardiology procedures since the opening of its Cardiology Clinic in May 2019, Gleneagles Hong Kong will continue its pursuit to be a pioneer in this field and support its medical team in embracing new technologies to benefit patients.

Topics:

Brands:

Related Stories

Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics

Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.

 

 

10 Oct 2019
Read More

Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme

Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.

10 Oct 2019
Read More

IHH Healthcare Wins Four Awards for Leadership and Learning Excellence

IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.

10 Oct 2019
Read More

IHH Healthcare Singapore Unveils Parkway Rehab and Healing Garden at Mount Elizabeth Hospital

The launch of Parkway Rehab and its Healing Garden marks a new chapter in patient rehabilitation, offering a supportive environment to help patients regain independence.

10 Oct 2019
Read More

A Monumental Message of Hope: Gleneagles Hospital Mumbai Sets Guinness World Record for Organ Donation Awareness

A 15.59-metre sculpture, a world record and a powerful message about the gift of life. Gleneagles Hospital Mumbai takes organ donation awareness beyond hospital walls and into the heart of the community.
10 Oct 2019
Read More

Gleneagles Hospital Hong Kong Advances Cross-Border Healthcare Innovation

Healthcare leaders gathered at BIOHK2026 to exchange ideas, share insights and explore new opportunities to advance healthcare innovation across borders.

10 Oct 2019
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo